share_log

Aptose Biosciences Says CFO Gregory Chow to Resign

Dow Jones Newswires ·  Mar 24, 2021 04:49

DJ Aptose Biosciences Says CFO Gregory Chow to Resign

By Stephen Nakrosis

Aptose Biosciences Inc. on Tuesday said Gregory Chow, the company's chief financial officer, is resigning "to pursue an opportunity at a private biopharma company."

Aptose said William Rice, the company's chairman, president and chief executive will serve as chief accounting officer until a permanent replacement is announced. The company's Chief Business Officer, Jotin Marango, will assume the duties of CFO until the replacement is announced, Aptose said.

Aptose also said it plans to enter into a consulting agreement with Mr. Chow that would be effective upon his March 26 departure.

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

March 23, 2021 16:49 ET (20:49 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment